The effects of such heterogeneous distribution in the tumor provides additional support to the requirement of a careful affinity optimization (not always affinity increases) to improve targeting in vivo, and illustrate the potential advantages of intermediate affinity variants like K4 and K5. Here, KRT5 is linked to neoplasm.